Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies

Bibliography

• Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med 2000;154:1226-9
   PubMedGoogle Scholar
• Parker MA, Sneddon AE, Arbon P. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG 2010;117:185-92
   PubMed Web of Science ®Google Scholar
• Mathias S, Kupperman M. Chronic pelvic pain: Prevalence, health-related quality of life, and economic correlates. Obstet Gynecol 1996;87:321-7
   PubMed Web of Science ®Google Scholar
• O'Connell K, Davis AR, Westhoff C. Self-treatment patterns among adolescent girls with dysmenorrhea. J Pediatr Adolesc Gynecol 2006;19:285-9
   PubMedGoogle Scholar
• Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration, and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynecol 1996;103:1134-42
   PubMedGoogle Scholar
• Balbi C, Musone R, Menditto A, Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. Eur J Obstet Gynecol Reprod Biol 2000;91:143-8
   PubMed Web of Science ®Google Scholar
• Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr 1995;49:508-16
   PubMed Web of Science ®Google Scholar
• Hornsby PP, Wilcox AJ, Weinber CR. Cigarette smoking and disturbance of menstrual function. Epidemiology 1998;9:193-8
   PubMed Web of Science ®Google Scholar
• Simpson JL, Bischoff FZ, Kamat A, Genetics of endometriosis. Obstet Gynecol Clin N Am 2003;30:21-40
   PubMed Web of Science ®Google Scholar
• James AH. More than menorrhagia: a review of the obstetric and gynaeological manifestations of bleeding disorders. Haempohilia 2005;11:295-307
   PubMed Web of Science ®Google Scholar
• Laufer MR. Identification of clear vesicular lesions of atypical endometriosis: a new technique. Fertil Steril 1997;68:739-40
   PubMed Web of Science ®Google Scholar
• Alvin PE, Litt IF. Current status of etiology and management of dysmenorrhea in adolescents. Pediatrics 1982;70:516-25
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438-63
   PubMed Web of Science ®Google Scholar
• Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006;108(2):428-41
   PubMed Web of Science ®Google Scholar
• Rees MCP, Di Marzo V, Tippins JR, Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. J Endocrinol 1987;113:291-5
   PubMed Web of Science ®Google Scholar
• Nigam S, Benedetto C, Zonca M, Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 1991;4:137-41
   PubMedGoogle Scholar
• Harel Z, Lilly C, Riggs S, Urinary Leukotriene (LT)-E4 in adolescents with dysmenorrhea. J Adolesc Health 2000;27:151-4
   PubMed Web of Science ®Google Scholar
• Valentin L, Sladkevicius P, Kindahl H, Effects of a vasopressin antagonist in women with dysmenorrhea. Gynecol Obstet Invest 2000;50:170-7
   PubMed Web of Science ®Google Scholar
• Cameron IT, Cambell S. Nitric oxide in the endometrium. Human Reprod Update 1998;4:565-9
   PubMed Web of Science ®Google Scholar
• Bulun SE. Endometriosis: Mechanisms of disease. N Engl J Med 2009;360:268-79
   PubMedGoogle Scholar
• Hornung D, Bentzien F, Wallwiener D, Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod 2001;7:163-8
   PubMed Web of Science ®Google Scholar
• Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 2002;123:217-26
   PubMed Web of Science ®Google Scholar
• Bulun SE, Yang S, Fang Z, Estrogen production and metabolism in endometriosis. Ann NY Acad Sci 2002;955:75-85
   PubMed Web of Science ®Google Scholar
• Matsuzaki S, Murakami T, Uehara S, Expression of estrogen receptor alpha and beta in periotoneal and ovarian endometriosis. Fertil Steril 2004;75:1198-205
   Google Scholar
• Keenan JA, Chen TT, Chadwell NL, IL-1 beta, TNF-alpha and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1995;34:381-5
   PubMed Web of Science ®Google Scholar
• Ota H, Igarashi S, Sasaki M, Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 2001;16:561-6
   PubMed Web of Science ®Google Scholar
• Tamura M, Deb S, Sebastian S, Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil Steril 2004;81:1351-6
   PubMed Web of Science ®Google Scholar
• Noble LS, Takayama K, Zeitoun KM, Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrionol Metab 1997;82:600-6
   PubMed Web of Science ®Google Scholar
• Chapron C, Fauconnier A, Dubuisson JB, Deep infiltrating endometriosis; relation between severity of dysmenorrhea and extent of disease. Hum Reprod 2003;18:760-6
   PubMed Web of Science ®Google Scholar
• Fedele L, Parazzini F, Bianchi S, Stage and localization of pelvic endometriosis and pain. Fertil Steril 1990;53:155-8
   PubMed Web of Science ®Google Scholar
• Menon S, Sammel MD, Vichnin M, Risk factors for ectopic pregnancy: a comparison between adults and adolescent women. J Pediatr Adolesc Gynecol 2007;20:181-5
   PubMed Web of Science ®Google Scholar
• Cox DJ, Meyer RG. Behavioral treatment parameters with primary dysmenorrhea. J Behav Med 1978;1:297-310
   PubMedGoogle Scholar
• Chatman DL, Ward AB. Endometriosis in adolescents. J Reprod Med 1982;27:156-60
   PubMed Web of Science ®Google Scholar
• Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005;4:CD004753
   PubMedGoogle Scholar
• Akin MD, Weingand KW, Hengehold DA, Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 2001;97:343-9
   PubMed Web of Science ®Google Scholar
• Kotani N, Sakai I, Hashimoto H, Analgesic effect of an herbal medicine for treatment of primary dysmenorrhea–a double blind study. Am J Chin Med 1997;25:205-12
   PubMed Web of Science ®Google Scholar
• Kaplan B, Rabinerson D, Lurie S, Clinical evaluation of a new model of transcutaneous electrical nerve stimulation device for the management of primary dysmenorrhea. Gynecol Obstet Invest 1997;44:255-9
   PubMed Web of Science ®Google Scholar
• Smith CA, Zhu X, He L, Acupuncture for primary dysmenorrhea. The Cochrane Database of Systematic Reviews 2011;1CD007854
   Google Scholar
• Rakhshaee Z. Effect of three yoga poses (cobra, cat, and fish poses) in women with primary dysmenorrhea: a randomized clinical trial. J Pediatr Adolesc Gynecol 2011;24:192-6
   PubMed Web of Science ®Google Scholar
• Golub LJ, Menduke H, Lang WR. Exercise and dysmenorrhea in young teenagers: a 3-year study. Obstet Gynecol 1968;32:508-11
   PubMed Web of Science ®Google Scholar
• Barnard ND, Scialli AR, Hurlock D, Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet Gynecol 2000;95:245-50
   PubMed Web of Science ®Google Scholar
• Harel Z, Biro FM, Kotenhahn RK, Supplementation with omega-3 fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996;174:1335-8
   PubMed Web of Science ®Google Scholar
• Mehlisch DR. Double-blind crossover comparison of ketoprofen, naproxen, and placebo in patients with primary dysmenorrhea. Clin Ther 1990;12:398-409
   PubMed Web of Science ®Google Scholar
• Mehlisch DR. Ketoprofen, ibuprofen, and placebo in the treatment of primary dysmenorrhea: a double-blind crossover comparison. J Clin Pharmacol 1998;28:S29-33
   Google Scholar
• Chantler I, Mitchell D, Fuller A. Diclofenac potassium attenuates dysmenorrhea and restores exercise performance in women with primary dysmenorrhea. J Pain 2009;10:191-200
   PubMedGoogle Scholar
• Zahradnik HP, Hanjalic-Beck A, Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea; a review. Contraception 2010;81:185-96
   PubMed Web of Science ®Google Scholar
• Boctor AM, Eickolt M, Pugsley TA. Meclofenamate sodium is an inhibitor of both the 5- lipoxygenase and cycloxygenase pathways of the arachidonic acid cascade in vitro. Prostaglandins Leukot Med 1986;23:229-338
   PubMedGoogle Scholar
• Owen PR. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Am J Obstet Gynecol 1984;148:96-103
   PubMed Web of Science ®Google Scholar
• Roy S. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea. Obstet Gynecol 1983;61:628-32
   PubMed Web of Science ®Google Scholar
• DuRant RH, Jay MS, Shofitt T. Factors influencing adolescents' responses to regimens of naproxen for dysmenorrhea. Am J Dis Child 1985;139:489-93
   PubMedGoogle Scholar
• Harel Z. Cyclooxygenase (COX)-2 specific inhibitors in the treatment of dysmenorrhea. J Pediatr Adolesc Gynecol 2004;17:75-9
   PubMedGoogle Scholar
• Daniels S, Robbins J, West C, Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies. Clin Ther 2009;31:1192-208
   PubMed Web of Science ®Google Scholar
• Dawood M. Non-steroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am J Med 1988;84:23-9
   PubMed Web of Science ®Google Scholar
• Harel Z, Riggs S, Vaz R, The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents. J Pediatr Adolesc Gynecol 2004;17:183-6
   PubMedGoogle Scholar
• Bieglmayer C, Hofer G, Kainz, et al. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 1995;9:307-12
   PubMed Web of Science ®Google Scholar
• Creatsas G, Deligeoroglou E, Zachari A, Prostaglandins: PGFalpha, PGE2, 6-keto-PGF1alpha and TXB serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Eur J Obstet Gynecol Reprod Biol 1990;36:292-8
   PubMed Web of Science ®Google Scholar
• Ekstrom P, Juchnicka E, Laudanski T, Effect of an oral contraceptive in primary dysmenorrhea–changes in uterine activity and reactivity to agonists. Contraception 1989;40:39-47
   PubMed Web of Science ®Google Scholar
• Ekstrom P, Akerlund M, Forsling M, Stimulation of vasopressin release in women with primary dysmenorrhea and after oral contraceptive treatment–effect on uterine contractility. Br J Obstet Gynaecol 1992;99:680-4
   PubMedGoogle Scholar
• Milsom I, Andersch B. Effect of various oral contraceptive combinations on dysmenorrhea. Gynecol Obstet Invest 1984;17:284-92
   PubMed Web of Science ®Google Scholar
• Larsson G, Milsom I, Lindstedt G, The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception 1992;46:327-34
   PubMed Web of Science ®Google Scholar
• Robinson JC, Plichata S, Weisman CS, Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am J Obstet Gynecol 1992;166:578-83
   PubMed Web of Science ®Google Scholar
• Ulstein M, Svendsen E, Steier A, Clinical experience with a triphasic oral contraceptive. Acta Obstet Gynecol Scand 1984;63:233-6
   PubMed Web of Science ®Google Scholar
• Davis AR, Westhoff C, O'Connell K, Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005;106:97-104
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Terakawa N, Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial. Fertility & Sterility 2011;95:1928-31
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Cressman BE, Waldrop E, Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997;89:179-83
   PubMed Web of Science ®Google Scholar
• Archer DF. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception 2006;74:359-66
   PubMed Web of Science ®Google Scholar
• Davis MG, Reape KZ, Hait H. A look at the long-term safety of an extended-regimen OC. J Family practice 2010;59:E9-E13
   Web of Science ®Google Scholar
• Ortiz A, Hiroi M, Stancyk FZ, Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of Depo-MPA. J Clin Endocrinol Metab 1977;44:32-8
   PubMed Web of Science ®Google Scholar
• Jain J, Dutton C, Nicosia A, Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception 2004;70:11-18
   PubMed Web of Science ®Google Scholar
• Harel Z, Biro F, Kollar L. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. J Adolesc Health 1995;16:379-84
   PubMed Web of Science ®Google Scholar
• Available from: Http://www.fda.gov/medwatch/SAFETY/2004/DepoProvera_Label.pdf [Accessed 27 January 2005]
   Google Scholar
• Cromer BA, Scholes D, Berenson A, Depot medroxyprogesterone acetate and bone mineral density in adolescents-the black box warning: a position paper of the Society for Adolescent Medicine. J Adolesc Health 2006;39:296-301
   PubMed Web of Science ®Google Scholar
• Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena®): a 3-year follow-up study. Contraception 2003;67:87-91
   PubMed Web of Science ®Google Scholar
• Aslam N, Blunt S, Latthe P. Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents. J of Obstet Gynaecol 2010;30:489-91
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 110. Noncontraceptive uses of hormonal contraceptives. Obstet Gynecol 2010;115:206-18
   PubMedGoogle Scholar
• Funk S, Miller MM, Mishell DR, Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319-26
   PubMed Web of Science ®Google Scholar
• Harel Z, Riggs S, Vaz R, Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol 2005;18:85-90
   PubMedGoogle Scholar
• Brucker C, Karck U, Merkle E. Cycle control, tolerability, efficacy and acceptability of the vaginal ring, NuvaRing®: Results of clinical experience in Germany. Eur J Contracept Reprod Health Care 2007;28:1-8
   Google Scholar
• Barreiros F, Guazzelli C, Barbosa R, Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects. Contraception 2010;81:223-5
   PubMed Web of Science ®Google Scholar
• Cook AS, Rock JA. Role of laparoscopy in the treatment of endometriosis. Fertil Steril 1991;55:663-80
   PubMed Web of Science ®Google Scholar
• Propst AM, Laufer MR. Endometriosis in adolescents: incidence, diagnosis, and treatment. J Reprod Med 1999;44:751-8
   PubMed Web of Science ®Google Scholar
• Doyle JO, Missmer SA, Laufer MR. The effect of standard medical-surgical intervention on progression of endometriosis. J Pediatr Adolesc Gynecol 2008;21:64-5
   Google Scholar
• Ling FW; For the Pelvic Pain Study Group. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol 1999;93:51-8
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Practice Bulletins–Gynecology. ACOG Practice Bulletin No. 51: chronic pelvic pain. Obstet Gynecol 2004;103:589-605
   PubMedGoogle Scholar
• ACOG Committee on Adolescent Health Care Opinion No. 310. Endometriosis in adolescents. Obstet Gynecol 2005;105:921-7
   PubMedGoogle Scholar
• Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 1997;4:CD001019
   Google Scholar
• Vercellini P, Barbara G, Somigliana E, Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril 2010;93:2150-61
   PubMed Web of Science ®Google Scholar
• Lubianca JN, Gordon CM, Laufer MR. “Add-back” therapy for endometriosis in adolescents. J Reprod Med 1998;43:164-72
   PubMed Web of Science ®Google Scholar
• Surrey ES, Hornstein MD. Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up. Obstet Gynecol 2002;99:709-19
   PubMed Web of Science ®Google Scholar
• DiVasta AD, Laufer MR, Gordon CM. Bone density in adolescents treated with a GnRH agonist and add-back therapy for endometriosis. J Pediatr Adolesc Gynecol 2007;20:293-7
   PubMed Web of Science ®Google Scholar
• Kupker W, Felberbaum RE, Krapp M, Use of GnRH antagonists in the treatment of endometriosis. Reprod Biomed Online 2002;5:12-16
   PubMedGoogle Scholar
• Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update 2006;12:179-89
   PubMed Web of Science ®Google Scholar
• Petta CA, Ferriani RA, Abrao MS, Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993-8
   PubMed Web of Science ®Google Scholar
• Walch K, Unfried G, Huber J, Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis–a pilot study. Contraception 2009;79:29-34
   PubMed Web of Science ®Google Scholar
• Ailawadi RK, Jobanputra S, Kataria M, Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate; a pilot study. Fertil Steril 2004;81:290-6
   PubMed Web of Science ®Google Scholar
• Amsterdam LL, Gentry W, Jobanputra S, Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005;84:300-4
   PubMed Web of Science ®Google Scholar
• Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril 2006;85:1307-18
   PubMed Web of Science ®Google Scholar
• Buzdar AU, Robertson JF, Eiermann W, An overview of the pharmacology and pharmacokinetics of the new generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer 2002;95:2006-16
   PubMed Web of Science ®Google Scholar
• Janicke F. Are all aromatase inhibitors the same? A review of the current evidence. Breast 2004;13(Suppl):10-18
   Google Scholar
• Chwalisz K, Perez MC, Demanno D, Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26:423-38
   PubMed Web of Science ®Google Scholar
• Chlouber RO, Olive DL, Pritts EA. Investigational drugs for endometriosis. Expert Opin Investig Drugs 2006;15:399-407
   PubMed Web of Science ®Google Scholar
• Jacobson TZ, Barlow DH, Garry R, Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2001;4:CD001300
   Google Scholar
• Sutton C, Pooley AS, Jones K D, A prospective, randomized, double-blind controlled trial of laparoscopic uterine nerve ablation in the treatment of pelvic pain associated with endometriosis. Gynaecol Endosc 2001;10:217-22
   Google Scholar
• Abbott J, Hawe J, Hunter D, Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril 2004;82:878-84
   PubMed Web of Science ®Google Scholar
• Hart R, Hickey M, Maouris P, Excisional surgery versus ablative surgery for ovarian endometriomata: a Cochrane Review. Hum Reprod 2005;20:3000-7
   PubMed Web of Science ®Google Scholar
• Tandoi I, Somigliana E, Riparini J, High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol 2011;24:376-9
   PubMed Web of Science ®Google Scholar
• Sanfilippo JS, Wakim NG, Schikler KN, Endometriosis in association with uterine anomaly. Am J Obstet Gynecol 1986;154:39-43
   PubMed Web of Science ®Google Scholar
• Strawbridge LC, Crouch NS, Cutner AS, Obstructive mullerian anomalies and modern laparoscopic management. J Pediatr Adolesc Gynecol 2007;20:195-200
   PubMed Web of Science ®Google Scholar